The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1.
Marked reduction in apoptosis is a hallmark of early colon tumour growth and the vast majority of these tumours exhibit a loss of expression of the glycoprotein carcinoembryonic-antigen-related cell adhesion molecule 1 (CEACAM1). We recently reported that the CEACAM1 functions as a mediator of apoptosis implicating this cell surface protein in early tumour development. However, the mechanistic involvement of CEACAM1 in cell death pathways is unclear. Here, we show that apoptosis triggers cleavage of the long form of CEACAM1 (CEACAM1-4L) at intracellular and extracellular sites in Jurkat cells and HEK293 cells. Signalling through CEACAM1 leads to caspase activation including caspase-1 and -3 and also involves non-caspase proteases. Moreover, we provide evidence that the naturally occurring CEACAM family member CEA is an inducer of CEACAM1-mediated apoptosis in HT29 colon cancer cells, an effect that depends on the abundance of CEACAM1 on the cell surface. Together, our results demonstrate that the CEACAM1-dependent cell death pathway involves dual cleavage of CEACAM1 and caspase activation and can be activated by CEA.
Nittka
S
S
Institute for Clinical Chemistry, University Hospital Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany.
Böhm
C
C
Zentgraf
H
H
Neumaier
M
M
D015703:Antigens, CD / Q000502:physiology*; D017209:Apoptosis; D002272:Carcinoembryonic Antigen / Q000494:pharmacology*; D020169:Caspases / Q000502:physiology; D015815:Cell Adhesion Molecules / Q000502:physiology*; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects
D015703:Antigens, CD; C069847:CD66 antigens; D002272:Carcinoembryonic Antigen; D015815:Cell Adhesion Molecules; D020169:Caspases